Department of Critical Care Medicine, Tianjin Medical University General Hospital, Tianjin, China.
Department of General Surgery, Tianjin Medical University General Hospital, Tianjin, China.
Front Cell Infect Microbiol. 2024 Nov 4;14:1488505. doi: 10.3389/fcimb.2024.1488505. eCollection 2024.
SAKI is a common and serious complication of sepsis, contributing significantly to high morbidity and mortality, especially in patients requiring RRT. Early identification of high-risk patients enables timely interventions and improvement in clinical outcomes. The objective of this study was to develop and validate a predictive model for in-hospital mortality in patients with SAKI receiving RRT.
Patients with SAKI receiving RRT from the MIMIC-IV database were retrospectively enrolled and randomly assigned to either the training cohort or the testing cohort in a 7:3 ratio. LASSO regression and Boruta algorithm were utilized for feature selection. Subsequently, three machine learning models-CART, SVM and LR-were constructed, and their predictive efficacy was assessed using a comprehensive set of performance indicators. Feature importance analysis was performed to determine the contribution of each feature to a model's predictions. Finally, DCA was employed to evaluate the clinical utility of the prediction models. Additionally, a clinical nomogram was developed to facilitate the interpretation and visualization of the LR model.
A total of 1663 adults were ultimately enrolled and randomly allocated into the training cohort (n = 1164) or the testing cohort (n = 499). Twenty-eight variables were evaluated for feature selection, with eight ultimately retained in the final model: age, MAP, RR, lactate, Cr, PT-INR, TBIL and CVP. The LR model demonstrated commendable performance, exhibiting robust discrimination in both the training cohort (AUROC: 0.73 (95% CI 0.70-0.76); AUPRC: 0.75 (95% CI 0.72-0.79); accuracy: 0.66 (95% CI 0.63-0.68)) and the testing cohort (AUROC: 0.72 (95% CI 0.68-0.76); AUPRC: 0.73 (95% CI 0.67-0.79); accuracy: 0.65 (95% CI 0.61-0.69)). Furthermore, there was good concordance between predicted and observed values in both the training cohort (χ2 = 4.41, p = 0.82) and the testing cohort (χ2 = 4.16, p = 0.84). The results of the DCA revealed that the LR model provided a greater net benefit compared to other prediction models.
The LR model exhibited superior performance in predicting in-hospital mortality in patients with SAKI receiving RRT, suggesting its potential utility in identifying high-risk patients and guiding clinical decision-making.
序贯器官衰竭评估(SOFA)评分是脓毒症患者发生急性肾损伤(AKI)的常见且严重的并发症,显著增加了患者的发病率和死亡率,尤其是需要肾脏替代治疗(RRT)的患者。早期识别高危患者可以及时进行干预,改善临床结局。本研究旨在开发和验证一个接受 RRT 的 AKI 患者院内死亡率的预测模型。
从 MIMIC-IV 数据库中回顾性纳入接受 RRT 的 AKI 患者,并按照 7:3 的比例随机分配到训练队列或测试队列。使用 LASSO 回归和 Boruta 算法进行特征选择。然后,构建了三个机器学习模型——决策树(CART)、支持向量机(SVM)和逻辑回归(LR),并使用一系列综合性能指标评估了它们的预测效果。通过特征重要性分析,确定了每个特征对模型预测的贡献。最后,使用决策曲线分析(DCA)评估预测模型的临床实用性。此外,还开发了一个临床列线图,以帮助解释和可视化 LR 模型。
最终纳入了 1663 名成年人,并随机分配到训练队列(n = 1164)或测试队列(n = 499)。评估了 28 个变量进行特征选择,最终有 8 个变量保留在最终模型中:年龄、平均动脉压(MAP)、呼吸频率(RR)、乳酸、肌酐(Cr)、凝血酶原时间国际标准化比值(PT-INR)、总胆红素(TBIL)和中心静脉压(CVP)。LR 模型表现出色,在训练队列(AUROC:0.73(95%CI 0.70-0.76);AUPRC:0.75(95%CI 0.72-0.79);准确率:0.66(95%CI 0.63-0.68))和测试队列(AUROC:0.72(95%CI 0.68-0.76);AUPRC:0.73(95%CI 0.67-0.79);准确率:0.65(95%CI 0.61-0.69))中均具有良好的区分度。此外,在训练队列(χ2 = 4.41,p = 0.82)和测试队列(χ2 = 4.16,p = 0.84)中,预测值与实际值之间均具有良好的一致性。DCA 的结果表明,LR 模型与其他预测模型相比提供了更大的净收益。
LR 模型在预测接受 RRT 的 AKI 患者的院内死亡率方面表现出优异的性能,提示其在识别高危患者和指导临床决策方面具有潜在的应用价值。